Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105099425 | 10509942 | 5 | F | 201310 | 20160720 | 20141010 | 20160728 | EXP | BR-AMGEN-BRASP2013076530 | AMGEN | 65.00 | YR | E | F | Y | 58.00000 | KG | 20160728 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105099425 | 10509942 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, ONCE WEEKLY (EVERY THURSDAY) | Y | H98943 | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | ||||
| 105099425 | 10509942 | 2 | C | CHLORTALIDONE | CHLORTHALIDONE | 1 | STRENGTH 25MG, 1X/DAY | 0 | 25 | MG | QD | ||||||||
| 105099425 | 10509942 | 3 | C | CHLORTALIDONE | CHLORTHALIDONE | 1 | STRENGTH 25MG, 1X/DAY | 0 | QD | ||||||||||
| 105099425 | 10509942 | 4 | C | ENALAPRIL MALEATE. | ENALAPRIL MALEATE | 1 | STENGTH 10MG, 1X/DAY | 0 | 10 | MG | QD | ||||||||
| 105099425 | 10509942 | 5 | C | ENALAPRIL MALEATE. | ENALAPRIL MALEATE | 1 | STENGTH 10MG, 1X/DAY | 0 | QD | ||||||||||
| 105099425 | 10509942 | 6 | C | OSCAL D | CALCIUM CARBONATECHOLECALCIFEROL | 1 | (STRENGTH 500MG), 2X/DAY | 0 | 500 | MG | BID | ||||||||
| 105099425 | 10509942 | 7 | C | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | STRENGTH 10MG, 1X/DAY | 0 | 10 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 105099425 | 10509942 | 1 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 105099425 | 10509942 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 105099425 | 10509942 | Injection site erythema | |
| 105099425 | 10509942 | Injection site pruritus | |
| 105099425 | 10509942 | Injection site swelling | |
| 105099425 | 10509942 | Joint injury | |
| 105099425 | 10509942 | Mobility decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 105099425 | 10509942 | 1 | 201308 | 0 | ||
| 105099425 | 10509942 | 7 | 2012 | 0 |